Form 4: Orthofix CFO Julie Andrews Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Orthofix Medical Inc. CFO Julie Andrews sold 4,655 shares of common stock to cover tax obligations related to the vesting of restricted stock units.
Summary
- Julie Andrews, CFO of Orthofix Medical Inc., sold 4,655 shares of common stock on January 16, 2025, at a price of $17.89 per share.
- The sale was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
- This transaction was part of a pre-existing sell-to-cover requirement approved by the company's Compensation and Talent Development Committee.
- Following the transaction, Andrews beneficially owns 28,312 shares, which includes 21,979 previously reported restricted stock units.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's outlook. The sentiment is neutral to slightly positive as it shows the executive is vested in the company's stock.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Sell-to-cover transactions are a standard practice across publicly traded companies, particularly in the technology and healthcare sectors where stock-based compensation is common.
- Similar transactions are regularly reported by executives at companies like Medtronic (MDT) and Stryker (SYK), which also utilize stock-based compensation.
- The number of shares sold and the price are within the typical range for such transactions, and the process is consistent with industry best practices for insider trading compliance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not indicate any change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/14/2025 | Date of execution of the Power of Attorney. |
| 01/16/2025 | Date of the stock sale transaction. |
| 01/21/2025 | Date the Form 4 was signed. |
Keywords
Orthofix, OFIX, Julie Andrews, CFO, stock sale, restricted stock units, tax obligations, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.